Welldoc Wins ‘Best Overall Digital Health Company’ for Third Consecutive Year in MedTech Breakthrough Awards
COLUMBIA, Md.–(BUSINESS WIRE)–Welldoc, a digital health leader revolutionizing AI-driven cardiometabolic care, has been selected as the winner of the “Best Overall Digital Health Company” award for the third consecutive year in the MedTech Breakthrough Awards. The annual awards program, conducted by MedTech Breakthrough, recognizes top companies in the global digital health and medical technology market.
This marks the fourth time MedTech Breakthrough has recognized Welldoc for its leadership and innovation in the digital health industry. Welldoc’s comprehensive AI-driven platform delivers flexible, multi-condition digital coaching across diabetes, hypertension, heart failure, prediabetes, and weight management, including GLP-1 support. The company enables health plans, health systems, and employers to extend traditional care models and partners with pharmaceutical and medical device industry leaders to develop first-in-class, regulated combination products.
Welldoc’s leadership is grounded in clinical rigor and regulatory expertise, demonstrated by over 90 clinical publications, 11 FDA 510(k) clearances for diabetes functionality, and 54 novel patents for their first-in-class AI technology. The company’s AI correlates insights across a broad spectrum of health data, offering actionable predictive capabilities to support improved health outcomes across multiple conditions.
“Precise personalization is not the future – it’s the present,” said Kevin McRaith, President and CEO of Welldoc. “Welldoc meets this need with our digital-first solutions focused on whole-person health. By proactively anticipating evolving AI guidelines, we are driving innovation and ensuring safety, accuracy, and adaptability in this rapidly evolving field.”
The MedTech Breakthrough Awards program celebrates excellence and innovation in various categories, including Telehealth, Clinical Administration, and Patient Engagement. This year’s program attracted nominations from over 18 countries, showcasing the global impact of the digital healthcare industry.
“Welldoc delivers a tailored solution for unique needs,” said Steve Johansson, Managing Director of MedTech Breakthrough. “At every step, Welldoc provides users with an effortless, intuitive, and engaging user experience. With personalized insights at their fingertips, individuals are better equipped to manage their health independently – enabling improved long-term outcomes.”
Welldoc is an FDA-cleared digital health solution that guides individuals through managing diabetes and other cardiometabolic conditions. The company partners with health plans, health systems, and employers to extend care, improve health, and reduce costs. With an extensive library of clinical research and an IP portfolio of 50 patents, Welldoc continues to be an industry thought leader in AI-driven cardiometabolic care.
